1. Home
  2. ANVS vs INVE Comparison

ANVS vs INVE Comparison

Compare ANVS & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • INVE
  • Stock Information
  • Founded
  • ANVS 2008
  • INVE 1990
  • Country
  • ANVS United States
  • INVE United States
  • Employees
  • ANVS N/A
  • INVE N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • INVE Computer peripheral equipment
  • Sector
  • ANVS Health Care
  • INVE Technology
  • Exchange
  • ANVS Nasdaq
  • INVE Nasdaq
  • Market Cap
  • ANVS 92.6M
  • INVE 86.5M
  • IPO Year
  • ANVS 2020
  • INVE 1997
  • Fundamental
  • Price
  • ANVS $2.31
  • INVE $3.55
  • Analyst Decision
  • ANVS Strong Buy
  • INVE Strong Buy
  • Analyst Count
  • ANVS 6
  • INVE 2
  • Target Price
  • ANVS $31.40
  • INVE $7.25
  • AVG Volume (30 Days)
  • ANVS 646.7K
  • INVE 30.2K
  • Earning Date
  • ANVS 03-31-2025
  • INVE 03-11-2025
  • Dividend Yield
  • ANVS N/A
  • INVE N/A
  • EPS Growth
  • ANVS N/A
  • INVE N/A
  • EPS
  • ANVS N/A
  • INVE 3.10
  • Revenue
  • ANVS N/A
  • INVE $104,217,000.00
  • Revenue This Year
  • ANVS N/A
  • INVE N/A
  • Revenue Next Year
  • ANVS N/A
  • INVE N/A
  • P/E Ratio
  • ANVS N/A
  • INVE $1.15
  • Revenue Growth
  • ANVS N/A
  • INVE 70.57
  • 52 Week Low
  • ANVS $2.22
  • INVE $2.95
  • 52 Week High
  • ANVS $20.00
  • INVE $9.24
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 19.91
  • INVE 47.28
  • Support Level
  • ANVS $2.44
  • INVE $3.41
  • Resistance Level
  • ANVS $2.79
  • INVE $3.67
  • Average True Range (ATR)
  • ANVS 0.31
  • INVE 0.18
  • MACD
  • ANVS -0.08
  • INVE 0.01
  • Stochastic Oscillator
  • ANVS 3.57
  • INVE 39.02

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

Share on Social Networks: